Universities purchase Elsevier's SciVal Spotlight tool to enhance research strategies

Multiple Leading Institutions Purchase New Strategic Decision-Support Tool

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced that several universities have purchased its new SciVal Spotlight tool. The institutions, including National Chiao Tung University (Taiwan), St. Petersburg University (Russia), University of Stellenbosch (South Africa) and the University of Vigo (Spain), will use the tool to analyze current output in order to enhance their near and long term research strategies.

SciVal Spotlight is a customizable web-based tool that offers institutions a multidisciplinary perspective of research performance. Using an innovative visualization technique, the tool produces customized maps that provide graphical views of an institution's research output over time and across scientific fields, focusing on specific topical areas.

"We've selected SciVal Spotlight to help us understand our competitive strengths as well as assist us in making the best possible investments for our university," said Chain-Shu Hsu, Vice President of National Chiao Tung University. "We are excited about the tailored insight the tool can offer and its ability to give us a better understanding of our position in the global research landscape."

"By pinpointing a university's topical strengths and identifying leading researchers and institutions in each area, SciVal Spotlight is designed to help academic decision-makers optimize funding allocations and enhance hiring and collaboration decisions," said Helen de Mooij, Academic & Government Products Group, Elsevier. "We are pleased at the interest we are seeing in the market as universities recognize the value the tool can offer in evaluating, establishing and executing research strategies."

SOURCE Elsevier

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients